retatrutide clinical trial status approval: FDA status, results, and when it could be available Triple hormone receptor agonist retatrutide – Triple hormone receptor agonist retatrutide – A Study of Retatrutide (LY3437943)
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
























